CSIR-CCMB identified critical weaknesses in Mycobacterium tuberculosis, potentially leading to new treatments for TB.
The research focuses on the protein export machinery of Mtb, crucial for its growth and pathogenicity, offering new drug targets.
Swipe up or tap below to access verified documents, statutory dockets, and interactive forensic breakdowns on DotMR.